The coronary angiography devices market size has grown strongly in recent years. It will grow from $10.03 billion in 2025 to $10.7 billion in 2026 at a compound annual growth rate (CAGR) of 6.7%. The growth in the historic period can be attributed to rising prevalence of coronary artery disease, increasing number of cardiac catheterization procedures, expansion of hospital cardiac care infrastructure, growing adoption of x-ray based angiography systems, improved awareness of early heart disease diagnosis.
The coronary angiography devices market size is expected to see strong growth in the next few years. It will grow to $13.83 billion in 2030 at a compound annual growth rate (CAGR) of 6.6%. The growth in the forecast period can be attributed to aging population with higher cardiovascular risk, increasing demand for early and accurate coronary diagnostics, expansion of interventional cardiology centers, rising adoption of image-guided cardiac procedures, growing focus on preventive cardiology care. Major trends in the forecast period include rising adoption of minimally invasive coronary diagnostic procedures, increasing use of advanced imaging systems in cardiac diagnostics, growing demand for high-precision coronary visualization, expansion of angiography use in early cardiac disease detection, increasing integration of diagnostic and therapeutic angiography workflows.
The rising prevalence of vascular heart diseases is anticipated to drive growth in the coronary angiography devices market moving forward. Vascular heart diseases include conditions affecting the blood vessels that supply the heart or exist within the heart itself. This increase in vascular heart disease cases is attributed to lifestyle changes, such as diet and physical activity, an aging population, and the growing rates of diabetes and hypertension. Coronary angiography devices assist in diagnosing and assessing vascular heart diseases by providing detailed images of the coronary arteries, allowing for precise identification of blockages, narrowing, and other abnormalities that inform treatment decisions. For example, in October 2024, according to the Centers for Disease Control and Prevention, a US-based government agency, cardiovascular disease claimed 919,032 lives in 2023, representing approximately one in every three deaths.Thus, the increasing prevalence of vascular heart diseases is propelling the coronary angiography devices market.
Major companies operating in the coronary angiography devices market are concentrating on developing technological innovations such as next-generation drug-eluting stents to improve procedural precision, patient outcomes, and long-term cardiovascular care. Next-generation drug-eluting stents are advanced devices featuring enhanced scaffolding, drug coatings, and deliverability to minimize restenosis and support optimal arterial healing. For example, in May 2024, Abbott Laboratories, a US-based medical devices company, launched its XIENCE Sierra stent in India. The stent provides cardiologists with greater flexibility, precise deployment, and improved safety, aiming to expand treatment options and raise the standard of care in coronary artery disease management. By combining advanced design and clinical insights, this launch promotes better procedural efficiency and patient-focused outcomes in interventional cardiology, while reinforcing Abbott’s commitment to innovation and advancing cardiovascular health globally.
In April 2023, Abbott, a U.S.-based medical device company, acquired Cardiovascular Systems, Inc. for an undisclosed amount. This acquisition aligns with Abbott's strategy to broaden its cardiovascular market portfolio, specifically in interventional therapies for peripheral and coronary artery diseases. By incorporating Cardiovascular Systems’ innovative technology and expertise, Abbott seeks to strengthen its capabilities and offerings in cardiovascular care. Cardiovascular Systems, Inc., a U.S.-based company, develops and sells products designed to treat coronary and peripheral vascular disease.
Major companies operating in the coronary angiography devices market are Cardinal Health Inc., Johnson & Johnson Services Inc., Abbott Laboratories, Medtronic plc, Siemens Healthineers AG, Koninklijke Philips N.V., GE HealthCare Technologies Inc., Boston Scientific Corporation, B. Braun Holding GmbH & Co. KG, Terumo Corporation, Nipro Corporation, Shimadzu Corporation, Cook Group Incorporated, ICU Medical Inc., Biotronik SE Co. KG, Merit Medical Systems Inc., Cordis Corporation, Guerbet N.V., AngioDynamics Inc., Canon Medical Systems Corporation, Acist Medical Systems, Medinol Ltd., Alvimedica.
North America was the largest region in the coronary angiography devices market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the coronary angiography devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the coronary angiography devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs are impacting the coronary angiography devices market by increasing costs for imported imaging components, contrast media, catheters, guidewires, and precision-manufactured accessories. These cost pressures have particularly affected angiography systems and consumable-intensive segments, with asia-pacific and europe facing higher exposure due to global manufacturing and sourcing dependencies. Increased tariffs have raised capital and procedural costs for hospitals and diagnostic centers. However, tariffs have also encouraged local manufacturing, regional sourcing, and supply chain diversification, supporting long-term market resilience.
The coronary angiography devices market research report is one of a series of new reports that provides coronary angiography devices market statistics, including coronary angiography devices industry global market size, regional shares, competitors with a coronary angiography devices market share, detailed coronary angiography devices market segments, market trends and opportunities, and any further data you may need to thrive in the coronary angiography devices industry. This coronary angiography devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Coronary angiography devices are medical instruments and systems designed to visualize the coronary arteries, which supply blood to the heart. These devices are used in diagnostic procedures to identify blockages, narrowing, or other abnormalities in these arteries. The process involves injecting a contrast dye into the coronary arteries and then using X-ray imaging to produce detailed pictures of the blood vessels.
The coronary angiography devices market includes several key products such as angiography systems, angiography catheters, angiography contrast media, vascular closure devices (VCDs), angiography balloons, angiography guidewires, and angiography accessories. Angiography systems are sophisticated imaging setups that provide real-time visualization of blood vessels using X-rays. These devices employ various technologies, such as X-ray angiography, computed tomography angiography (CTA), magnetic resonance angiography, and others, to address conditions such as coronary artery disease, valvular heart disease, congenital heart disease, and congestive heart failure. They are used in both diagnostic and therapeutic applications, serving end-users such as hospitals, clinics, diagnostic and imaging centers, and research institutes.
The coronary angiography devices market consists of revenues earned by entities by providing services such as imaging and diagnostic procedures, patient preparation and monitoring, and interventional treatments. The market value includes the value of related goods sold by the service provider or included within the service offering. The coronary angiography devices market also includes sales of angiography systems, contrast media injectors, guidewires, and catheters. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
The coronary angiography devices market size is expected to see strong growth in the next few years. It will grow to $13.83 billion in 2030 at a compound annual growth rate (CAGR) of 6.6%. The growth in the forecast period can be attributed to aging population with higher cardiovascular risk, increasing demand for early and accurate coronary diagnostics, expansion of interventional cardiology centers, rising adoption of image-guided cardiac procedures, growing focus on preventive cardiology care. Major trends in the forecast period include rising adoption of minimally invasive coronary diagnostic procedures, increasing use of advanced imaging systems in cardiac diagnostics, growing demand for high-precision coronary visualization, expansion of angiography use in early cardiac disease detection, increasing integration of diagnostic and therapeutic angiography workflows.
The rising prevalence of vascular heart diseases is anticipated to drive growth in the coronary angiography devices market moving forward. Vascular heart diseases include conditions affecting the blood vessels that supply the heart or exist within the heart itself. This increase in vascular heart disease cases is attributed to lifestyle changes, such as diet and physical activity, an aging population, and the growing rates of diabetes and hypertension. Coronary angiography devices assist in diagnosing and assessing vascular heart diseases by providing detailed images of the coronary arteries, allowing for precise identification of blockages, narrowing, and other abnormalities that inform treatment decisions. For example, in October 2024, according to the Centers for Disease Control and Prevention, a US-based government agency, cardiovascular disease claimed 919,032 lives in 2023, representing approximately one in every three deaths.Thus, the increasing prevalence of vascular heart diseases is propelling the coronary angiography devices market.
Major companies operating in the coronary angiography devices market are concentrating on developing technological innovations such as next-generation drug-eluting stents to improve procedural precision, patient outcomes, and long-term cardiovascular care. Next-generation drug-eluting stents are advanced devices featuring enhanced scaffolding, drug coatings, and deliverability to minimize restenosis and support optimal arterial healing. For example, in May 2024, Abbott Laboratories, a US-based medical devices company, launched its XIENCE Sierra stent in India. The stent provides cardiologists with greater flexibility, precise deployment, and improved safety, aiming to expand treatment options and raise the standard of care in coronary artery disease management. By combining advanced design and clinical insights, this launch promotes better procedural efficiency and patient-focused outcomes in interventional cardiology, while reinforcing Abbott’s commitment to innovation and advancing cardiovascular health globally.
In April 2023, Abbott, a U.S.-based medical device company, acquired Cardiovascular Systems, Inc. for an undisclosed amount. This acquisition aligns with Abbott's strategy to broaden its cardiovascular market portfolio, specifically in interventional therapies for peripheral and coronary artery diseases. By incorporating Cardiovascular Systems’ innovative technology and expertise, Abbott seeks to strengthen its capabilities and offerings in cardiovascular care. Cardiovascular Systems, Inc., a U.S.-based company, develops and sells products designed to treat coronary and peripheral vascular disease.
Major companies operating in the coronary angiography devices market are Cardinal Health Inc., Johnson & Johnson Services Inc., Abbott Laboratories, Medtronic plc, Siemens Healthineers AG, Koninklijke Philips N.V., GE HealthCare Technologies Inc., Boston Scientific Corporation, B. Braun Holding GmbH & Co. KG, Terumo Corporation, Nipro Corporation, Shimadzu Corporation, Cook Group Incorporated, ICU Medical Inc., Biotronik SE Co. KG, Merit Medical Systems Inc., Cordis Corporation, Guerbet N.V., AngioDynamics Inc., Canon Medical Systems Corporation, Acist Medical Systems, Medinol Ltd., Alvimedica.
North America was the largest region in the coronary angiography devices market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the coronary angiography devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the coronary angiography devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs are impacting the coronary angiography devices market by increasing costs for imported imaging components, contrast media, catheters, guidewires, and precision-manufactured accessories. These cost pressures have particularly affected angiography systems and consumable-intensive segments, with asia-pacific and europe facing higher exposure due to global manufacturing and sourcing dependencies. Increased tariffs have raised capital and procedural costs for hospitals and diagnostic centers. However, tariffs have also encouraged local manufacturing, regional sourcing, and supply chain diversification, supporting long-term market resilience.
The coronary angiography devices market research report is one of a series of new reports that provides coronary angiography devices market statistics, including coronary angiography devices industry global market size, regional shares, competitors with a coronary angiography devices market share, detailed coronary angiography devices market segments, market trends and opportunities, and any further data you may need to thrive in the coronary angiography devices industry. This coronary angiography devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Coronary angiography devices are medical instruments and systems designed to visualize the coronary arteries, which supply blood to the heart. These devices are used in diagnostic procedures to identify blockages, narrowing, or other abnormalities in these arteries. The process involves injecting a contrast dye into the coronary arteries and then using X-ray imaging to produce detailed pictures of the blood vessels.
The coronary angiography devices market includes several key products such as angiography systems, angiography catheters, angiography contrast media, vascular closure devices (VCDs), angiography balloons, angiography guidewires, and angiography accessories. Angiography systems are sophisticated imaging setups that provide real-time visualization of blood vessels using X-rays. These devices employ various technologies, such as X-ray angiography, computed tomography angiography (CTA), magnetic resonance angiography, and others, to address conditions such as coronary artery disease, valvular heart disease, congenital heart disease, and congestive heart failure. They are used in both diagnostic and therapeutic applications, serving end-users such as hospitals, clinics, diagnostic and imaging centers, and research institutes.
The coronary angiography devices market consists of revenues earned by entities by providing services such as imaging and diagnostic procedures, patient preparation and monitoring, and interventional treatments. The market value includes the value of related goods sold by the service provider or included within the service offering. The coronary angiography devices market also includes sales of angiography systems, contrast media injectors, guidewires, and catheters. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
Table of Contents
1. Executive Summary
2. Coronary Angiography Devices Market Characteristics
3. Coronary Angiography Devices Market Supply Chain Analysis
4. Global Coronary Angiography Devices Market Trends and Strategies
5. Coronary Angiography Devices Market Analysis of End Use Industries
7. Global Coronary Angiography Devices Strategic Analysis Framework, Current Market Size, Market Comparisons and Growth Rate Analysis
8. Global Coronary Angiography Devices Total Addressable Market (TAM) Analysis for the Market
9. Coronary Angiography Devices Market Segmentation
10. Coronary Angiography Devices Market Regional and Country Analysis
11. Asia-Pacific Coronary Angiography Devices Market
12. China Coronary Angiography Devices Market
13. India Coronary Angiography Devices Market
14. Japan Coronary Angiography Devices Market
15. Australia Coronary Angiography Devices Market
16. Indonesia Coronary Angiography Devices Market
17. South Korea Coronary Angiography Devices Market
18. Taiwan Coronary Angiography Devices Market
19. South East Asia Coronary Angiography Devices Market
20. Western Europe Coronary Angiography Devices Market
21. UK Coronary Angiography Devices Market
22. Germany Coronary Angiography Devices Market
23. France Coronary Angiography Devices Market
24. Italy Coronary Angiography Devices Market
25. Spain Coronary Angiography Devices Market
26. Eastern Europe Coronary Angiography Devices Market
27. Russia Coronary Angiography Devices Market
28. North America Coronary Angiography Devices Market
29. USA Coronary Angiography Devices Market
30. Canada Coronary Angiography Devices Market
31. South America Coronary Angiography Devices Market
32. Brazil Coronary Angiography Devices Market
33. Middle East Coronary Angiography Devices Market
34. Africa Coronary Angiography Devices Market
36. Coronary Angiography Devices Market Competitive Landscape and Company Profiles
37. Coronary Angiography Devices Market Other Major and Innovative Companies
40. Coronary Angiography Devices Market High Potential Countries, Segments and Strategies
41. Appendix
List of Tables
Executive Summary
Coronary Angiography Devices Market Global Report 2026 provides strategists, marketers and senior management with the critical information they need to assess the market.This report focuses coronary angiography devices market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase:
- Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
- Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on end user analysis.
- Benchmark performance against key competitors based on market share, innovation, and brand strength.
- Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
- Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
- Report will be updated with the latest data and delivered to you along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Description
Where is the largest and fastest growing market for coronary angiography devices? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The coronary angiography devices market global report answers all these questions and many more.The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
- The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
- The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
- The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
- The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
- The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
- Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.
Report Scope
Markets Covered:
1) By Product Type: Angiography Systems; Angiography Catheters; Angiography Contrast Media; Vascular Closure Devices (VCDs); Angiography Balloons; Angiography Guidewires; Angiography Accessories2) By Technology: X-Ray Angiography; Computed Tomography Angiography (CTA); Magnetic Resonance Angiography; Other Technologies
3) By Indication: Coronary Artery Disease; Valvular Heart Disease; Congenital Heart Disease; Congestive Heart Failure; Other Indications
4) By Application: Diagnostics; Therapeutics
5) By End-User: Hospital And Clinics; Diagnostic And Imaging Centers; Research Institutes
Subsegments:
1) By Angiography Systems: X-Ray Angiography Systems; 3D Or 4D Angiography Systems; Digital Subtraction Angiography (DSA) Systems2) By Angiography Catheters: Diagnostic Catheters; Therapeutic Catheters; Over-The-Wire (OTW) Catheters; Rapid Exchange (RX) Catheters
3) By Angiography Contrast Media: Iodinated Contrast Media; Non-Iodinated Contrast Media
4) By Vascular Closure Devices (VCDs): Mechanical VCDs; Passive Hemostasis VCDs; Active Hemostasis VCDs
5) By Angiography Balloons: High-Pressure Balloons; Low-Pressure Balloons; Drug-Eluting Balloons
6) By Angiography Guidewires: Standard Guidewires; Supportive Guidewires; Steerable Guidewires
7) By Angiography Accessories: Introducer Sheaths; Inflation Devices; Syringes And Needles; Guidewire Support Systems
Companies Mentioned: Cardinal Health Inc.; Johnson & Johnson Services Inc.; Abbott Laboratories; Medtronic plc; Siemens Healthineers AG; Koninklijke Philips N.V.; GE HealthCare Technologies Inc.; Boston Scientific Corporation; B. Braun Holding GmbH & Co. KG; Terumo Corporation; Nipro Corporation; Shimadzu Corporation; Cook Group Incorporated; ICU Medical Inc.; Biotronik SE Co. KG; Merit Medical Systems Inc.; Cordis Corporation; Guerbet N.V.; AngioDynamics Inc.; Canon Medical Systems Corporation; Acist Medical Systems; Medinol Ltd.; Alvimedica
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita.
Data Segmentation: Country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: Word, PDF or Interactive Report + Excel Dashboard
Added Benefits:
- Bi-Annual Data Update
- Customisation
- Expert Consultant Support
Companies Mentioned
The companies featured in this Coronary Angiography Devices market report include:- Cardinal Health Inc.
- Johnson & Johnson Services Inc.
- Abbott Laboratories
- Medtronic plc
- Siemens Healthineers AG
- Koninklijke Philips N.V.
- GE HealthCare Technologies Inc.
- Boston Scientific Corporation
- B. Braun Holding GmbH & Co. KG
- Terumo Corporation
- Nipro Corporation
- Shimadzu Corporation
- Cook Group Incorporated
- ICU Medical Inc.
- Biotronik SE Co. KG
- Merit Medical Systems Inc.
- Cordis Corporation
- Guerbet N.V.
- AngioDynamics Inc.
- Canon Medical Systems Corporation
- Acist Medical Systems
- Medinol Ltd.
- Alvimedica
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 250 |
| Published | February 2026 |
| Forecast Period | 2026 - 2030 |
| Estimated Market Value ( USD | $ 10.7 Billion |
| Forecasted Market Value ( USD | $ 13.83 Billion |
| Compound Annual Growth Rate | 6.6% |
| Regions Covered | Global |
| No. of Companies Mentioned | 24 |
